Kancharla Krishna, Weissman Gaby, Elagha Abdalla A, Kancherla Kalyan, Samineni Swetha, Hill Peter C, Boyce Steven, Fuisz Anthon R
Department of cardiology, Mayo Clinic, Rochester, 55905, MN, USA.
Division of Cardiology, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, DC, USA.
J Cardiovasc Magn Reson. 2016 Jul 18;18(1):45. doi: 10.1186/s12968-016-0265-y.
Scar burden by late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) is associated with functional recovery after coronary artery bypass surgery (CABG). There is limited data on long-term mortality after CABG based on left ventricular (LV) scar burden.
Patients who underwent LGE CMR between January 2003 and February 2010 within 1 month prior to CABG were included. A standard 16 segment model was used for scar quantification. A score of 1 for no scar, 2 for ≤ 50 % and 3 for > 50 % transmurality was assigned for each segment. LV scar score (LVSS) defined as the sum of segment scores divided by 16. All-cause mortality was ascertained by social security death index.
One hundred ninety-six patients met the inclusion criteria. 185 CMR studies were available. History of prior MI was present in 64 % and prior CABG in 5.4 % of patients. Scar was present in 72 % of patients and median LVEF was 38 %. Over a median follow up of 8.3 years, there were 64 deaths (34.6 %). There was no statistically significant difference in mortality between Scar and No-scar groups (37 % versus 29 %). In the group with scar, a lower scar burden (defined either < 4 segments with scar or based on LVSS) was independently associated with increased survival.
In patients undergoing surgical revascularization, scar burden is negatively associated with survival in patients with scar. However, there is no difference in survival based on presence or absence of scar alone. CMR prior to CABG adds additional prognostic information.
延迟钆增强(LGE)心血管磁共振成像(CMR)所显示的瘢痕负荷与冠状动脉旁路移植术(CABG)后的功能恢复相关。基于左心室(LV)瘢痕负荷的CABG术后长期死亡率的数据有限。
纳入2003年1月至2010年2月期间在CABG术前1个月内接受LGE CMR检查的患者。采用标准的16节段模型进行瘢痕定量分析。每个节段无瘢痕记为1分,≤50%透壁性瘢痕记为2分,>50%透壁性瘢痕记为3分。左心室瘢痕评分(LVSS)定义为节段评分总和除以16。通过社会保障死亡指数确定全因死亡率。
196例患者符合纳入标准。获得了185份CMR研究资料。64%的患者有既往心肌梗死病史,5.4%的患者有既往CABG病史。72%的患者存在瘢痕,左心室射血分数(LVEF)中位数为38%。中位随访8.3年,有64例死亡(34.6%)。瘢痕组和无瘢痕组的死亡率无统计学显著差异(37%对29%)。在有瘢痕的组中,较低的瘢痕负荷(定义为瘢痕节段<4个或基于LVSS)与生存率增加独立相关。
在接受外科血运重建的患者中,瘢痕负荷与有瘢痕患者的生存率呈负相关。然而,仅根据有无瘢痕,生存率并无差异。CABG术前的CMR可提供额外的预后信息。